The Design, Synthesis, and Biological Evaluation of Novel Peptidic Ligands for the Treatment of Chronic Neuropathic Pain
Chronic neuropathic pain is a disease that impacts the livelihood of millions of people in the United States with no effective pain treatments and limited information pertaining to the underlying mechanisms. Opioid therapy is considered the gold standard for pain therapeutics, but chronic use of the...
Main Author: | Remesic, Michael Vincent |
---|---|
Other Authors: | Hruby, Victor J. |
Language: | en_US |
Published: |
The University of Arizona.
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/625593 http://arizona.openrepository.com/arizona/handle/10150/625593 |
Similar Items
-
Bradykinin Ligands and Receptors Involved in Neuropathic Pain
by: Hall, Sara M.
Published: (2015) -
Cyclic Opioid Peptides.
by: Remesic, Michael, et al.
Published: (2016) -
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
by: Adriano Mollica, et al.
Published: (2017-01-01) -
Novel Bifunctional Ligands For Neuropathic Pain: Design and Synthesis of Overlapping Pharmacophores of Opioid and Melanocortin Ligands
by: Kulkarni, Vinod V.
Published: (2012) -
Development of Dibenzothiazepine Derivatives as Multifunctional Compounds for Neuropathic Pain
by: Han, X., et al.
Published: (2022)